FSA First Formal Novel Food Approvals UK CBD
The UK Food Standards Agency (FSA) has officially moved to recommend market authorization for the first batch of high-purity CBD novel food applications. This decision marks the beginning of the end for the temporary FSA Public List, signaling a shift toward permanent legal approval for compliant products, enforced mandatory safety labeling, and the strict removal of unauthorized CBD imports across Great Britain.
For over seven years, the UK cannabidiol (CBD) market operated in a state of regulatory limbo. Since January 2019, when the Food Standards Agency (FSA) classified CBD ingestibles—such as oils, sprays, gummies, capsules, and infused drinks—as "Novel Foods," no brand had achieved formal authorization.
To keep products on store shelves while applications were assessed, the FSA introduced the Public List of CBD Products. Inclusion on this public ledger meant a brand had submitted a validated novel food application, permitting its products to be provisionally sold in England and Wales. However, the Public List was never intended to be permanent.
A landmark shift arrived when the FSA Board officially backed the first batch of CBD Novel Food applications for full authorization. This development marks the beginning of the end for the temporary Public List and signals a transition toward a fully regulated UK hemp and CBD industry.
What Did the FSA Decide?
The FSA’s scientific risk assessments culminated in formal recommendations to UK ministers to approve three core CBD raw material applications:
Application RP7: Pure Synthetic CBD
Application RP350: High-purity CBD Isolate
Application RP427: Plant-derived CBD Isolate (from industrial hemp)
These approved applications cover formulations consisting of 98% or higher purity CBD. Over 3,000 retail products currently listed on the FSA’s Public List are linked to these primary supply chains.
What Changes for UK Consumers?
1. Mandatory Product Warnings
Under the conditions of formal approval, all finished products authorized under these applications must feature standardized mandatory warnings on their packaging:
Not suitable for individuals under 18 years of age.
Not suitable for pregnant, breastfeeding, or trying-to-conceive individuals.
Cautionary guidance for individuals taking prescription medication or with compromised immune systems.
2. Reinforcement of the 10mg Daily Guideline
The FSA reiterated its Acceptable Daily Intake (ADI) threshold, recommending that healthy adults limit daily CBD consumption to 10mg per day (roughly equivalent to 4–5 drops of a standard 5% CBD oil).
3. Phasing Out Unapproved "Grey Market" Goods
Products on the FSA Public List whose underlying applications fail to meet safety and toxicological data requirements will be systematically removed from the market. Unapproved, unlisted, or non-compliant CBD imports will face stricter enforcement and removal from physical store shelves and e-commerce platforms across Great Britain.
4. Clear Separation of Controlled Cannabinoid Rules
Novel food authorization covers food safety, toxicology, and manufacturing consistency. It remains distinct from Home Office drug regulations. Brands must still ensure finished retail containers do not exceed the statutory limit of 1mg of controlled cannabinoids (THC/CBN) per finished unit.
What’s Next?
The FSA board's recommendation has been submitted to health ministers in England and Wales for final legal signing. Food Standards Scotland (FSS) manages a parallel process in Scotland, while Northern Ireland continues to follow European Union framework guidelines.
For consumers and retailers, this milestone brings long-awaited clarity. While products currently on the Public List remain legal to purchase during the transition phase, the market is officially moving toward a structured environment where only thoroughly tested, fully authorized CBD products can be sold legally in the UK.
References and Sources
The news regarding the FSA's first CBD novel food authorization recommendations was published and reported across several regulatory news outlets and official government bodies:
Food Standards Agency (GOV.UK)
Source: FSA Business Guidance & Data Catalog – CBD products linked to novel food applications
Summary: Official registry tracking validated applications (RP7, RP350, RP427) and public list updates.
The Chemical Engineer
Article Title: Regulator to recommend market authorisation for CBD products in England and Wales
Publication Date: September 11, 2026
Global Cosmetics News
Article Title: UK Food Standards Agency Moves First CBD Novel Foods Towards Authorisation
Publication Date: September 8, 2026
Food Compliance International
Article Title: FSA Agency recommends authorizing the first three cannabidiol products as novel foods under strict usage conditions
Publication Date: September 3, 2026
Evopure Regulatory Insights
Article Title: The FSA's First CBD Approvals Explained: What Changes for UK Buyers
Publication Date: September 30, 2026